AffiREC® Recombinant Human soluble Tumor Necrosis Factor Receptor Type II/TNFRSF1B
CAT# AFG-BTL-17879
Size: 5 μg
AffiREC® Recombinant Human soluble Tumor Necrosis Factor Receptor Type II/TNFRSF1B
Research Area
Others.
Purity
> 97 % by SDS-PAGE and HPLC analyses..
Source
N/A.
Biological Activity
Fully biologically active when compared to standard. The ED50 as determined by its ability to inhibit the TNF-α mediated cytotoxicity in the L-929 cells is less than 0.2 μg/ml, corresponding to a specific activity of > 5000 IU/mg in the presence of 0.25 ng/mL of rHuTNF-α..Synonyms
sTNF RII/TNFRSF1B, CD120b, TBPII, TNF-R-II, TNF-R75, TNFBR, TNFR1B, TNFR2, TNFR80, p75, p75TNFR, Human.
Molecular Weight
Approximately 20.0 kDa, a single non-glycosylated polypeptide chain containing 184 amino acids..
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS, pH 7.4..
Storage & Stability
-20ºC